Aller au contenu principal
Accès ouvert déclaré 2022 article

Functional and clinical studies reveal pathophysiological complexity of CLCN4-related neurodevelopmental condition

35Citations signalées, ce qui n’est pas une note de qualité
84Institutions déclarées
14Pays d’affiliation déclarés

Rattachement africain : au, es, de, se, fr, lb, sa, be, us, gb, ca, no, nl, pt. Niveau de preuve : code pays fourni par la source.

Le résumé fourni par la source

Missense and truncating variants in the X-chromosome-linked CLCN4 gene, resulting in reduced or complete loss-of-function (LOF) of the encoded chloride/proton exchanger ClC-4, were recently demonstrated to cause a neurocognitive phenotype in both males and females. Through international clinical matchmaking and interrogation of public variant databases we assembled a database of 90 rare CLCN4 missense variants in 90 families: 41 unique and 18 recurrent variants in 49 families. For 43 families, including 22 males and 33 females, we collated detailed clinical and segregation data. To confirm causality of variants and to obtain insight into disease mechanisms, we investigated the effect on electrophysiological properties of 59 of the variants in Xenopus oocytes using extended voltage and pH ranges. Detailed analyses revealed new pathophysiological mechanisms: 25% (15/59) of variants demonstrated LOF, characterized by a "shift" of the voltage-dependent activation to more positive voltages, and nine variants resulted in a toxic gain-of-function, associated with a disrupted gate allowing inward transport at negative voltages. Functional results were not always in line with in silico pathogenicity scores, highlighting the complexity of pathogenicity assessment for accurate genetic counselling. The complex neurocognitive and psychiatric manifestations of this condition, and hitherto under-recognized impacts on growth, gastrointestinal function, and motor control are discussed. Including published cases, we summarize features in 122 individuals from 67 families with CLCN4-related neurodevelopmental condition and suggest future research directions with the aim of improving the integrated care for individuals with this diagnosis.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
Functional and clinical studies reveal pathophysiological complexity of CLCN4-related neurodevelopmental condition
Date Crossref
16/11/2022
Éditeur
Springer Science and Business Media LLC
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.

Les institutions déclarées

UNSW SydneySydney Children's HospitalSydney Children’s Hospitals NetworkInstituto di BiofisicaLiverpool HospitalMax Planck Institute for Molecular GeneticsLinköping UniversityFondation Jérôme-LejeuneLebanese American UniversityCentre National de la Recherche ScientifiqueInsermCentre Hospitalier Universitaire de NantesInstitut du ThoraxGénétique Médicale & Génomique FonctionelleNantes UniversitéKing Faisal Specialist Hospital & Research CentreAntwerp University HospitalVIB-UAntwerp Center for Molecular NeurologyUniversity of AntwerpGhent University HospitalChildren's Hospital at WestmeadCentre Hospitalier Universitaire de ToursAkron Children's HospitalHeidelberg UniversityUniversity of TübingenGreat Ormond Street HospitalUniversity College LondonPrincess Anne HospitalKing Edward Memorial HospitalThe University of QueenslandWashington University in St. LouisGarvan Institute of Medical ResearchMurdoch Children's Research InstituteHospital for Sick ChildrenHunter GeneticsUniversity of Newcastle AustraliaChildren's Mercy HospitalUniversity of Missouri–Kansas CityHôpitaux Universitaires de StrasbourgUniversité de StrasbourgHôpital Civil, StrasbourgHaukeland University HospitalUniversity of ManchesterGenomics (United Kingdom)Manchester University NHS Foundation TrustColumbia University Irving Medical CenterTexas Tech University Health Sciences CenterIntegrative Health Technologies (United States)Hillcrest ClinicsInstitute of Pathology and GeneticsRoyal Prince Alfred HospitalChildren's Hospital of Eastern OntarioBrooke Army Medical CenterThe University of Texas at San Antonio Health Science CenterUrology San AntonioRadboud University NijmegenRadboud University Medical CenterPlurynCentro Hospitalar do PortoUniversidade do PortoUniversité de BordeauxCentre Hospitalier Universitaire de BordeauxBordeaux Population HealthBiotherapy of Genetic Diseases, Inflammatory Disorders and CancersIndiana University School of MedicineIndiana University – Purdue University IndianapolisUniversity of California San DiegoRady Children's Hospital-San DiegoLondon North West Healthcare NHS TrustImperial College LondonQueen Elizabeth University HospitalVrije Universiteit BrusselUniversitair Ziekenhuis BrusselCentre Hospitalier Universitaire Sainte-JustineUniversité de MontréalTexas A&M Health Science CenterTexas A&M UniversityLeiden UniversityBaylor College of MedicineBaylor GeneticsCentogene (Germany)Ambry Genetics (United States)CHU Dinant Godinne UCL NamurAddenbrooke's Hospital

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Les sujets associés

Glycogen Storage Diseases and MyoclonusNeurological disorders and treatmentsGenetics and Neurodevelopmental Disorders

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.